RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-4901
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_0403200; Gene model (P.falciparum): PF3D7_0304600; Gene product: circumsporozoite (CS) protein (CSP)
Details mutation: A series of mutants expressing an additional copy of CSP, tagged with GFP at different locations
TaggedGene model (rodent): PBANKA_0403200; Gene model (P.falciparum): PF3D7_0304600; Gene product: circumsporozoite (CS) protein (CSP)
Name tag: GFP
Phenotype Oocyst; Sporozoite;
Last modified: 19 February 2021, 13:57
  *RMgm-4901
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 33600048
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherSinger M, Frischknecht F
Name Group/DepartmentIntegrative Parasitology, Center for Infectious Diseases
Name InstituteHeidelberg University Medical School
CityHeidelberg
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-4901
Principal namesee below
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNormal numbers of oocysts are produced in all 5 lines.
Sporozoite'Normal' sporozoite formation inside oocysts.
Investigating the GFP-CSP localization revealed that all but the two SP-GFP-CSP lines showed the expected surface localization of the fusion proteins. Close inspection also revealed that the GPI-GFP expressing parasite often showed additional small vesicular localization in the proximity of the plasma membrane at the estimated nuclear exit site or Golgi localization.
R-GFP-CSP and TSR-GFP-CSP but not SP-GFP-CSP localize to the plasma membrane.
Strongly reduced numbers of salivary gland sporozoites. Evidence is presented that the expression of tagged proteins inhibited sporozoite egress from oocysts.
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
A series of mutants are described that express an additional copy of CSP that is tagged with GFP at different locations in the protein.  

Protein (function)
The CS protein is the major protein on the surface of sporozoites and is critical for development of sporozoites within the oocysts and is involved in motility and invasion of both the salivary gland of the mosquito and the liver cells. The protein is also found on the oocyst plasma membrane and on the inner surface of the oocyst capsule. Specific motifs in CS are involved in sporozoite binding to mosquito salivary glands and in sporozoite attachment to heparan sulfate proteoglycans in the liver of the mammalian host. During substrate-dependent locomotion of sporozoites, CS is secreted at the sporozoite anterior pole, translocated along the sporozoite axis and released on the substrate at the sporozoite posterior pole. Following sporozoite invasion of hepatocytes, the CS is released in the host cell cytoplasm.

Phenotype
The following five parasite lines were generated:
- GFP-GPI, parasites expressing a protein consisting of the signal peptide of CSP, GFP and the C-terminal 22 amino acids of CSP corresponding to the GPI-anchor sequence. This line was obtained through insertion at a silent locus in chromosome 12 of P. berghei strain ANKA.
- SP-GFP-CSP_add, parasites expressing a CSP-GFP fusion protein with the GFP placed between the signal peptide (SP) and the N-terminus of CSP. This line, expressed SP-GFP-CSP in addition to the endogenous CSP and was obtained by linear insertion of the sp-gfp-csp plasmid into the csp locus on chromosome 4.
- SP-GFP-CSP_rep, where the endogenous csp was replaced by the sp-gfp-csp gene.
- R-GFP-CSP, where the GFP was placed between the repeat region and TSR of CSP
- TSR-GFP-CSP; where the GFP was placed between the TSR and the GPI-anchor. Exact positioning of the GFP insertion sites for R-GFP-CSP and TSR-GFP-CSP was assisted by the crystal structure of the TSR domain. In these lines, the fusion proteins were also expressed in addition to the endogenous CSP as obtained by linear insertion of the respective plasmids into the csp locus on chromosome 4. Note that for SP-GFP-CSP_add, the DNA is inserted such that the resulting modified locus features an endogenous csp with a truncated 3’UTR and the fluorescent copy a truncated 5’UTR, while this is inversed for R-GFP-CSP and TSR-GFP-CSP. For SP-GFP-CSP_rep, the gene is flanked by the complete 5’UTR and 3’UTR.

See the paper for a detailed Figure of the modifications/tagging of CSP and explanation about processing events

Normal numbers of oocysts are produced in all 5 lines. 'Normal' sporozoite formation inside oocysts.
Investigating the GFP-CSP localization revealed that all but the two SP-GFP-CSP lines showed the expected surface localization of the fusion proteins. Close inspection also revealed that the GPI-GFP expressing parasite often showed additional small vesicular localization in the proximity of the plasma membrane at the estimated nuclear exit site or Golgi localization.
R-GFP-CSP and TSR-GFP-CSP but not SP-GFP-CSP localize to the plasma membrane.

Strongly reduced numbers of salivary gland sporozoites. Evidence is presented that the expression of tagged proteins inhibited sporozoite egress from oocysts.

Additional information

Other mutants


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0403200
Gene Model P. falciparum ortholog PF3D7_0304600
Gene productcircumsporozoite (CS) protein
Gene product: Alternative nameCSP
Details of the genetic modification
Short description of the mutationA series of mutants expressing an additional copy of CSP, tagged with GFP at different locations
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe following five parasite lines were generated:
- GFP-GPI, parasites expressing a protein consisting of the signal peptide of CSP, GFP and the C-terminal 22 amino acids of CSP corresponding to the GPI-anchor sequence. This line was obtained through insertion at a silent locus in chromosome 12 of P. berghei strain ANKA.
- SP-GFP-CSP_add, parasites expressing a CSP-GFP fusion protein with the GFP placed between the signal peptide (SP) and the N-terminus of CSP. This line, expressed SP-GFP-CSP in addition to the endogenous CSP and was obtained by linear insertion of the sp-gfp-csp plasmid into the csp locus on chromosome 4.
- SP-GFP-CSP_rep, where the endogenous csp was replaced by the sp-gfp-csp gene.
- R-GFP-CSP, where the GFP was placed between the repeat region and TSR of CSP
- TSR-GFP-CSP; where the GFP was placed between the TSR and the GPI-anchor. Exact positioning of the GFP insertion sites for R-GFP-CSP and TSR-GFP-CSP was assisted by the crystal structure of the TSR domain. In these lines, the fusion proteins were also expressed in addition to the endogenous CSP as obtained by linear insertion of the respective plasmids into the csp locus on chromosome 4. Note that for SP-GFP-CSP_add, the DNA is inserted such that the resulting modified locus features an endogenous csp with a truncated 3’UTR and the fluorescent copy a truncated 5’UTR, while this is inversed for R-GFP-CSP and TSR-GFP-CSP. For SP-GFP-CSP_rep, the gene is flanked by the complete 5’UTR and 3’UTR.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0403200
Gene Model P. falciparum ortholog PF3D7_0304600
Gene productcircumsporozoite (CS) protein
Gene product: Alternative nameCSP
Details of the genetic modification
Name of the tagGFP
Details of taggingdifferent locations in the protein
Additional remarks: taggingA series of mutants expressing an additional copy of CSP, tagged with GFP at different locations
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe following five parasite lines were generated:
- GFP-GPI, parasites expressing a protein consisting of the signal peptide of CSP, GFP and the C-terminal 22 amino acids of CSP corresponding to the GPI-anchor sequence. This line was obtained through insertion at a silent locus in chromosome 12 of P. berghei strain ANKA.
- SP-GFP-CSP_add, parasites expressing a CSP-GFP fusion protein with the GFP placed between the signal peptide (SP) and the N-terminus of CSP. This line, expressed SP-GFP-CSP in addition to the endogenous CSP and was obtained by linear insertion of the sp-gfp-csp plasmid into the csp locus on chromosome 4.
- SP-GFP-CSP_rep, where the endogenous csp was replaced by the sp-gfp-csp gene.
- R-GFP-CSP, where the GFP was placed between the repeat region and TSR of CSP
- TSR-GFP-CSP; where the GFP was placed between the TSR and the GPI-anchor. Exact positioning of the GFP insertion sites for R-GFP-CSP and TSR-GFP-CSP was assisted by the crystal structure of the TSR domain. In these lines, the fusion proteins were also expressed in addition to the endogenous CSP as obtained by linear insertion of the respective plasmids into the csp locus on chromosome 4. Note that for SP-GFP-CSP_add, the DNA is inserted such that the resulting modified locus features an endogenous csp with a truncated 3’UTR and the fluorescent copy a truncated 5’UTR, while this is inversed for R-GFP-CSP and TSR-GFP-CSP. For SP-GFP-CSP_rep, the gene is flanked by the complete 5’UTR and 3’UTR.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6